Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
15 studies found for:    stop-it
Show Display Options
Rank Status Study
1 Unknown  Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission
Condition: Crohn Disease
Interventions: Drug: Infliximab;   Other: Placebo
2 Completed The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo
3 Unknown  Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze
Conditions: Bleeding;   Coagulopathy
Intervention: Device: pad-gauze with tranexamic acid (Hemostopan™)
4 Recruiting Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: fulvestrant;   Drug: anastrozole
5 Unknown  Zibotentan Better Renal Scleroderma Outcome Study
Conditions: Scleroderma;   Scleroderma Renal Crisis;   Chronic Kidney Disease
Intervention: Drug: Zibotentan
6 Recruiting Jointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Game;   Other: Usual Care
7 Recruiting An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease
Conditions: COPD;   Interstitial Lung Disease
Intervention: Procedure: Cell therapy
8 Completed Pharmacodynamics of CNP During Growth Hormone Treatment
Conditions: Pituitary Dwarfism;   Idiopathic Short Stature
9 Withdrawn Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer
Condition: Neoplasms, Breast
Interventions: Drug: Lapatinib;   Drug: Trastuzumab;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Paclitaxel
10 Completed Body Image Issues in Boys Being Treated at the Royal Marsden
Condition: Cancer
11 Recruiting Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Anemia;   Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Horse Anti-Thymocyte Globulin (ATG);   Drug: Cyclosporine A (CSA)
12 Completed GW572016 to Treat Recurrent Malignant Brain Tumors
Conditions: Glioma;   Brain Tumor;   Glioblastoma Multiforme;   GBM;   Gliosarcoma;   GS
Interventions: Drug: lapatinib ditosylate;   Procedure: Adjuvant therapy;   Procedure: Conventional surgery;   Procedure: Neoadjuvant therapy
13 Unknown  A Trial of Clay Weight on the Ear Drum for Patulous Eustachian Tube
Condition: Patulous Eustachian Tube Dysfunction
Intervention: Device: Clay
14 Completed
Has Results
Oral Paricalcitol in Kidney Transplant Recipients
Conditions: Transplant; Failure, Kidney;   Renal Disease, End Stage;   Hyperparathyroidism, Secondary
Interventions: Drug: Paricalcitol;   Other: Corticosteroid Avoidance Immune Suppression Protocol
15 Completed Efficacy and Safety of Two Treatment Models in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: adalimumab;   Drug: prednisone;   Drug: azathioprine

Study has passed its completion date and status has not been verified in more than two years.